icon
0%

Leidos Holdings LDOS - News Analyzed: 5,400 - Last Week: 100 - Last Month: 400

↑ Leidos Holdings: A Bio-Tech Market Leader Facing Fluctuations, Strategic Alliances, and a Focus on Cybersecurity

Leidos Holdings: A Bio-Tech Market Leader Facing Fluctuations, Strategic Alliances, and a Focus on Cybersecurity
Leidos Holdings, Inc. (LDOS) has seen considerable fluctuations and strategic moves recently. The prominent biotech company's shares have been bought and sold by a number of investment firms, including Blue Trust Inc. and Pacer Advisors Inc.. Robeco Institutional Asset Management B.V. also increased its positions in LDOS. Despite the company's shares being under pressure, its institutional shareholders who possess 77% of the company still control LDOS predominantly. Furthermore, partnering with Nauticus Robotics, LDOS steps towards a pivotal underwater tech alliance. Another significant development is their award for a $120 million Naval cybersecurity contract for defense and intelligence agencies. Despite some decline in stock performance, the company's declared quarterly cash dividend. Leading analysts have given an interesting future outlook, predicting the LDOS stock to rise in the future although the growth outlook moderates for 2025 according to TD Cowen. In terms of products, Leidos' increased focus on cybersecurity services has gained them the title of one of the Wall Street's favorite to invest in. Fiduciary Alliance LLC, Harbor Investment Advisory LLC, and Ritholtz Wealth Management are among the organizations that have recently increased their LDOS holdings. However, the future expectations lie in their upcoming Q4 2024 earnings call and investors are eager to see whether LDOS will continue their record growth.

Leidos Holdings LDOS News Analytics from Tue, 30 Jul 2024 07:00:00 GMT to Sat, 01 Feb 2025 09:24:20 GMT - Rating 6 - Innovation 8 - Information 9 - Rumor 3

The email address you have entered is invalid.